Stockreport

Revance Reports Fourth Quarter and Full Year 2023 Financial Results, Provides Corporate Update [Yahoo! Finance]

Revance Therapeutics, Inc.  (RVNC) 
Last revance therapeutics, inc. earnings: 2/24 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.revance.com
PDF – Q4 DAXXIFY volume up 22% over Q3 2023, with over two-thirds of Q4 revenue attributable to reordering accounts. – 2024 product revenue guidance of at least $280 mill [Read more]